Literature DB >> 25922207

Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.

Dennis R Trune1, Beth Kempton2, Frances A Hausman2, Barbara E Larrain2, Carol J MacArthur2.   

Abstract

Although the inner ear has long been reported to be susceptible to middle ear disease, little is known of the inflammatory mechanisms that might cause permanent sensorineural hearing loss. Recent studies have shown inner ear tissues are capable of expressing inflammatory cytokines during otitis media. However, little quantitative information is available concerning cytokine gene expression in the inner ear and the protein products that result. Therefore, this study was conducted of mouse middle and inner ear during acute otitis media to measure the relationship between inflammatory cytokine genes and their protein products with quantitative RT-PCR and ELISA, respectively. Balb/c mice were inoculated transtympanically with heat-killed Haemophilus influenzae and middle and inner ear tissues collected for either quantitative RT-PCR microarrays or ELISA multiplex arrays. mRNA for several cytokine genes was significantly increased in both the middle and inner ear at 6 h. In the inner ear, these included MIP-2 (448 fold), IL-6 (126 fold), IL-1β (7.8 fold), IL-10 (10.7 fold), TNFα (1.8 fold), and IL-1α (1.5 fold). The 24 h samples showed a similar pattern of gene expression, although generally at lower levels. In parallel, the ELISA showed the related cytokines were present in the inner ear at concentrations higher by 2-122 fold higher at 18 h, declining slightly from there at 24 h. Immunohistochemistry with antibodies to a number of these cytokines demonstrated they occurred in greater amounts in the inner ear tissues. These findings demonstrate considerable inflammatory gene expression and gene products in the inner ear following acute otitis media. These higher cytokine levels suggest one potential mechanism for the permanent hearing loss seen in some cases of acute and chronic otitis media.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25922207      PMCID: PMC4492826          DOI: 10.1016/j.heares.2015.04.006

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  30 in total

Review 1.  Breaking the wall: targeting of the endothelium by pathogenic bacteria.

Authors:  Emmanuel Lemichez; Marc Lecuit; Xavier Nassif; Sandrine Bourdoulous
Journal:  Nat Rev Microbiol       Date:  2009-12-30       Impact factor: 60.633

2.  IL-1beta causes an increase in intestinal epithelial tight junction permeability.

Authors:  Rana M Al-Sadi; Thomas Y Ma
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium.

Authors:  Shaomin Peng; Geliang Gan; Veena S Rao; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-27       Impact factor: 4.799

4.  Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

Authors:  Carol J MacArthur; J Beth Kempton; Jacqueline DeGagne; Dennis R Trune
Journal:  Otolaryngol Head Neck Surg       Date:  2008-11       Impact factor: 3.497

5.  A comparative study of intratympanic steroid and NO synthase inhibitor for treatment of cochlear lateral wall damage due to acute otitis media.

Authors:  Michihiko Sone; Hideo Hayashi; Hiroshi Yamamoto; Mitsuo Tominaga; Tsutomu Nakashima
Journal:  Eur J Pharmacol       Date:  2003-12-15       Impact factor: 4.432

6.  Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells.

Authors:  Jae Young Choi; Yoon-Seok Choi; Su Jin Kim; Eun Jin Son; Hyun Seung Choi; Joo-Heon Yoon
Journal:  Eur J Pharmacol       Date:  2007-04-22       Impact factor: 4.432

7.  Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.

Authors:  Sung K Moon; Jeong-Im Woo; Haa-Yung Lee; Raekil Park; Jun Shimada; Huiqi Pan; Robert Gellibolian; David J Lim
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

8.  Expression of adhesion molecules by cultured spiral ligament fibrocytes stimulated with proinflammatory cytokines.

Authors:  Issei Ichimiya; Kazuhide Yoshida; Masashi Suzuki; Goro Mogi
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-08       Impact factor: 1.547

9.  Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs.

Authors:  Sara A Tokarz; Jiaqing Pang; Anna Grosz; J Beth Kempton; Dennis R Trune; De-Ann M Pillers
Journal:  Acta Otolaryngol       Date:  2013-07       Impact factor: 1.494

10.  Inner ear tissue remodeling and ion homeostasis gene alteration in murine chronic otitis media.

Authors:  Carol J MacArthur; Fran Hausman; J Beth Kempton; Nathan Sautter; Dennis R Trune
Journal:  Otol Neurotol       Date:  2013-02       Impact factor: 2.311

View more
  9 in total

1.  Cmah deficiency may lead to age-related hearing loss by influencing miRNA-PPAR mediated signaling pathway.

Authors:  Juhong Zhang; Na Wang; Anting Xu
Journal:  PeerJ       Date:  2019-05-17       Impact factor: 2.984

2.  Cytokine Levels in Inner Ear Fluid of Young and Aged Mice as Molecular Biomarkers of Noise-Induced Hearing Loss.

Authors:  Lukas D Landegger; Sasa Vasilijic; Takeshi Fujita; Vitor Y Soares; Richard Seist; Lei Xu; Konstantina M Stankovic
Journal:  Front Neurol       Date:  2019-09-11       Impact factor: 4.003

Review 3.  Subversion of host immune responses by otopathogens during otitis media.

Authors:  James M Parrish; Manasi Soni; Rahul Mittal
Journal:  J Leukoc Biol       Date:  2019-05-10       Impact factor: 4.962

4.  Up-Regulated Expression of Interferon-Gamma, Interleukin-6 and Tumor Necrosis Factor-Alpha in the Endolymphatic Sac of Meniere's Disease Suggesting the Local Inflammatory Response Underlies the Mechanism of This Disease.

Authors:  Chao Huang; Qin Wang; Xueying Pan; Wei Li; Wei Liu; Wenqi Jiang; Li Huang; Anquan Peng; Zhiwen Zhang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

5.  Chronic suppurative otitis media causes macrophage-associated sensorineural hearing loss.

Authors:  Anping Xia; Anthony Thai; Zhixin Cao; Xiaohua Chen; Jing Chen; Brian Bacacao; Laurent A Bekale; Viktoria Schiel; Paul L Bollyky; Peter L Santa Maria
Journal:  J Neuroinflammation       Date:  2022-09-12       Impact factor: 9.587

6.  Trans-cortical vessels in the mouse temporal bulla bone are a means to recruit myeloid cells in chronic otitis media and limit peripheral leukogram changes.

Authors:  Ali Azar; Mahmood F Bhutta; Jorge Del-Pozo; Elspeth Milne; Michael Cheeseman
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

7.  Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

Authors:  Limeng Wu; Sasa Vasilijic; Yao Sun; Jie Chen; Lukas D Landegger; Yanling Zhang; Wenjianlong Zhou; Jun Ren; Samuel Early; Zhenzhen Yin; William W Ho; Na Zhang; Xing Gao; Grace Y Lee; Meenal Datta; Jessica E Sagers; Alyssa Brown; Alona Muzikansky; Anat Stemmer-Rachamimov; Luo Zhang; Scott R Plotkin; Rakesh K Jain; Konstantina M Stankovic; Lei Xu
Journal:  Sci Transl Med       Date:  2021-07-14       Impact factor: 19.319

8.  Interleukin-10 Attenuates Hypochlorous Acid-Mediated Cytotoxicity to HEI-OC1 Cochlear Cells.

Authors:  Martin Mwangi; Sung-Hee Kil; David Phak; Hun Yi Park; David J Lim; Raekil Park; Sung K Moon
Journal:  Front Cell Neurosci       Date:  2017-10-06       Impact factor: 5.505

Review 9.  Otitis media.

Authors:  Anne G M Schilder; Tasnee Chonmaitree; Allan W Cripps; Richard M Rosenfeld; Margaretha L Casselbrant; Mark P Haggard; Roderick P Venekamp
Journal:  Nat Rev Dis Primers       Date:  2016-09-08       Impact factor: 52.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.